4//SEC Filing
Francisco David 4
Accession 0001062993-22-004796
CIK 0001661181other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:51 PM ET
Size
9.8 KB
Accession
0001062993-22-004796
Insider Transaction Report
Form 4
Francisco David
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2022-02-15+40,348→ 56,709 total - Tax Payment
Class A Common Stock
2022-02-15$8.03/sh−1,876$15,064→ 54,833 total - Tax Payment
Class A Common Stock
2022-02-16$7.78/sh−953$7,414→ 53,880 total - Award
Stock Option (Right to Buy)
2022-02-15+95,692→ 95,692 totalExercise: $8.03Exp: 2032-02-15→ Class A Common Stock (95,692 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022.
- [F2]The option becomes exercisable in equal annual installments over four years beginning February 15, 2022.
Issuer
Organogenesis Holdings Inc.
CIK 0001661181
Entity typeother
Related Parties
1- filerCIK 0001846282
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 6:51 PM ET
- Size
- 9.8 KB